Abstract:
It is clear that there is a distinct new clinical entity of acquired immune deficiency which manifests itself by opportunistic infections and KS. It occurs in selected groups of the population but with an ever increasing spectrum. The clinical presentation is extremely varied and the spectrum of disease runs a wide gamut. Health professionals should be aware that there is a large pool of individuals at risk for AIDS; also AIDS may manifest itself in the limited forms with mild initial signs which continue for months before serious disease becomes apparent. There is at present no specific diagnostic laboratory test to identify these patients or those at greatest risk. Present evidence indicates that once life-threatening opportunistic infections or KS have become obvious, although the disease process may wax and wane, most patients follow an inexorable downhill course. That process has not been reversed by presently applied therapies. In view of the failure of conventional and experimental therapies, the only treatment appears to be prevention of disease by avoiding risk factors. With the ever increasing number of possible risk factors identified, such avoidance becomes continually more difficult. The most pressing problem is to delineate the pathogenesis of AIDS. Until then optimal preventive and therapeutic interventions can not be instituted fully. There are a number of major unanswered questions, foremost of which is the nature of the transmittable agent. Moreover, it is not entirely clear who is susceptible to this agent. With the vast numbers at risk and growing numbers of AIDS cases, it is imperative to uncover the initial events responsible for this syndrome. From the public health point of view, it is also crucial to determine whether those individuals in the high risk groups which exhibit immunological abnormalities will, given a long enough latent period, eventually progress to AIDS/KS or whether the majority are merely a forme fruste of AIDS. Because of the major public health impact of AIDS, all physicians should be aware of and knowledgeable about this new disease process.
Keywords: beta 2-Microglobulin/ANALYSIS *Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/ETIOLOGY/ TRANSMISSION Body Weight Female Fever/COMPLICATIONS Human Killer Cells, Natural/IMMUNOLOGY Lymphadenitis/COMPLICATIONS Lymphopenia/ETIOLOGY Male Pneumonia, Pneumocystis carinii/COMPLICATIONS Sarcoma, Kaposi's/COMPLICATIONS Skin Neoplasms/COMPLICATIONS Support, U.S. Gov't, P.H.S. T-Lymphocytes/CLASSIFICATION/IMMUNOLOGY JOURNAL ARTICLE REVIEW
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.
